- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medison introduces two new ultrasound systems
The Medison SonoAce 9900 is a fully digital Windows NT 2000-based ultrasound system with multispecialty applications in general imaging, ob/gyn, perinatology, cardiology, vascular, small parts, musculoskeletal, and urology. Medison of Cypress, CA,
The Medison SonoAce 9900 is a fully digital Windows NT 2000-based ultrasound system with multispecialty applications in general imaging, ob/gyn, perinatology, cardiology, vascular, small parts, musculoskeletal, and urology.
Medison of Cypress, CA, introduced the new system at this months Federation of International Gynecology and Obstetrics (FIGO) meeting in Washington, DC.
The SonoAce 9900 incorporates digital multibeam signal processing supporting phased-sector, curved, endovaginal, and linear array transducers. The transducer frequency range is from 1 MHz to 12 MHz. The system includes M-Mode, color Doppler, pulsed and continuous-wave Doppler, and power Doppler capabilities.
Digital 3-D imaging offers multibeam signal processing capability allowing 3-D in such applications as power Doppler and multiplanar imaging. The SonoAce 9900 includes the 3-D volume quantification method, Virtual Organ Computer Aided Analysis (VOCAL), to assess the volume of anatomical structures and masses.
Medisons Voluson 730 ultrasound system is a premium high-end, fully digital Windows NT 2000-based ultrasound system that will replace the Voluson 530D. The new systems digital platform is designed to expand current technologies and the possibilities for future applications. The 2000 digital platform offers capabilities for enhancing tissue information display; an increased frame rate, to define fast-moving structures; and the first real-time 4-D volume imaging, for higher quality results and a significant increase in available diagnostic information.
The Voluson 730 provides true real-time volume data acquisition to image fetal movement without any artifacts or loss of information. The system also offers 3-D volume quantification, advanced harmonic imaging, a quad digital beamformer, and online remote diagnostics. FDA clearance is pending.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
